Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Short-term Investments (2022 - 2023)

Historic Short-term Investments for Alaunos Therapeutics (TCRT) over the last 2 years, with Q1 2023 value amounting to $13.9 million.

  • Alaunos Therapeutics' Short-term Investments changed N/A to $13.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $13.9 million, marking a year-over-year change of. This contributed to the annual value of $13.9 million for FY2022, which is N/A changed from last year.
  • Alaunos Therapeutics' Short-term Investments amounted to $13.9 million in Q1 2023.
  • Alaunos Therapeutics' Short-term Investments' 5-year high stood at $13.9 million during Q3 2022, with a 5-year trough of $13.9 million in Q3 2022.